rs28730713
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001232.4(CASQ2):c.985C>T(p.Pro329Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,613,686 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P329T) has been classified as Uncertain significance.
Frequency
Consequence
NM_001232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASQ2 | ENST00000261448.6 | c.985C>T | p.Pro329Ser | missense_variant | Exon 10 of 11 | 1 | NM_001232.4 | ENSP00000261448.5 | ||
CASQ2 | ENST00000488931.2 | n.*357C>T | non_coding_transcript_exon_variant | Exon 12 of 13 | 3 | ENSP00000518226.1 | ||||
CASQ2 | ENST00000488931.2 | n.*357C>T | 3_prime_UTR_variant | Exon 12 of 13 | 3 | ENSP00000518226.1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000228 AC: 57AN: 250268Hom.: 0 AF XY: 0.000207 AC XY: 28AN XY: 135264
GnomAD4 exome AF: 0.000223 AC: 326AN: 1461372Hom.: 0 Cov.: 30 AF XY: 0.000201 AC XY: 146AN XY: 726942
GnomAD4 genome AF: 0.000230 AC: 35AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74476
ClinVar
Submissions by phenotype
not provided Uncertain:6
- -
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 28404607, 25163546, 30847666) -
- -
Variant summary: The c.985C>T (p.Pro329Ser) in CASQ2 gene is a missense change that involves a conserved nucleotide and 5/5 in silico tools predict deleterious outcome. The variant is present in the control population dataset of ExAC at frequency of 0.00035. The observed frequency does not exceed the maximum expected allele frequency for a pathogenic CASQ2 variant of 0.0044, however, it is possible that variant may be a rare functional polymorphism. The variant was identified in compound heterozygosity in at least 1 DCM pt (Haas, 2015). The variant of interest has been reported as VUS by reputable databases/clinical laboratories. More definitive data are needed. Taking together, the variant was classified as VUS until more information becomes available. -
- -
- -
Catecholaminergic polymorphic ventricular tachycardia 2 Uncertain:3
- -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
The CASQ2 c.985C>T; p.Pro329Ser variant (rs28730713, ClinVar Variation ID: 190747) is reported in the literature in cardiac-related disease cohorts (Haas 2015, Landstrom 2017, Ng 2017, van Lint 2019). This variant is found in the general population with an overall allele frequency of 0.02% (68/281,674 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is deleterious (REVEL: 0.741). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Haas J et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J. 2015 May 7;36(18):1123-35a. PMID: 25163546. Landstrom AP et al. Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals. Circ Arrhythm Electrophysiol. 2017 Apr;10(4):e004742. PMID: 28404607. Ng D et al. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. PMID: 23861362. van Lint FHM et al. Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance. Neth Heart J. 2019 Jun;27(6):304-309. PMID: 30847666. -
Cardiomyopathy Uncertain:1
- -
Catecholaminergic polymorphic ventricular tachycardia 1;C2677794:Catecholaminergic polymorphic ventricular tachycardia 2 Uncertain:1
- -
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 329 of the CASQ2 protein (p.Pro329Ser). This variant is present in population databases (rs28730713, gnomAD 0.07%). This missense change has been observed in individual(s) with arrhythmia (PMID: 30847666). ClinVar contains an entry for this variant (Variation ID: 190747). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The c.985C>T (p.P329S) alteration is located in exon 10 (coding exon 10) of the CASQ2 gene. This alteration results from a C to T substitution at nucleotide position 985, causing the proline (P) at amino acid position 329 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at